Structural basis for inhibition of the AAA-ATPase Drg1 by diazaborine - Prattes, Michael; Grishkovskaya, Irina; Hodirnau, Victor-Valentin; Rössler, Ingrid; Klein, Isabella; Hetzmannseder, Christina; Zisser, Gertrude; Gruber, Christian C.; Gruber, Karl; Haselbach, David; Bergler, Helmut (Nature Communications, 2021)
The hexameric AAA-ATPase Drg1 is a key factor in eukaryotic ribosome biogenesis and initiates cytoplasmic maturation of the large ribosomal subunit by releasing the shuttling maturation factor Rlp24. Drg1 monomers contain two AAA-domains (D1 and D2) that act in a concerted manner. Rlp24 release is inhibited by the drug diazaborine which blocks ATP hydrolysis in D2. The mode of inhibition was unknown. Here we show the first cryo-EM structure of Drg1 revealing the inhibitory mechanism. Diazaborine forms a covalent bond to the 2′-OH of the nucleotide in D2, explaining its specificity for this site. As a consequence, the D2 domain is locked in a rigid, inactive state, stalling the whole Drg1 hexamer. Resistance mechanisms identified include abolished drug binding and altered positioning of the nucleotide. Our results suggest nucleotide-modifying compounds as potential novel inhibitors for AAA-ATPases.
published
yes
Keywords: article; General Biochemistry -- Genetics and Molecular Biology -- General Physics and Astronomy -- General Chemistry